EverSource Wealth Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.8K Sell
365
-175
-32% -$9.45K ﹤0.01% 2249
2026
Q1
$28.2K Buy
540
+39
+8% +$2.34K ﹤0.01% 2273
2025
Q4
$29.5K Buy
501
+9
+2% +$547 ﹤0.01% 2125
2025
Q3
$27.4K Sell
492
-181
-27% -$9.7K ﹤0.01% 2123
2025
Q2
$34.6K Buy
673
+562
+506% +$28.2K ﹤0.01% 1872
2025
Q1
$6.51K Hold
111
﹤0.01% 2360
2024
Q4
$8K Sell
111
-102
-48% -$7.49K ﹤0.01% 2115
2024
Q3
$17K Sell
213
-42
-16% -$3.16K ﹤0.01% 1575
2024
Q2
$20.8K Sell
255
-81
-24% -$5.96K ﹤0.01% 1490
2024
Q1
$21.2K Buy
336
+58
+21% +$4.15K ﹤0.01% 1329
2023
Q4
$21.4K Buy
278
+265
+2,038% +$17.5K ﹤0.01% 1205
2023
Q3
$884 Sell
13
-144
-92% -$11.4K ﹤0.01% 2279
2023
Q2
$12.8K Buy
157
+15
+11% +$1.21K ﹤0.01% 1335
2023
Q1
$10.5K Buy
142
+138
+3,450% +$10.6K ﹤0.01% 1329
2022
Q4
$332 Hold
4
﹤0.01% 2237
2022
Q3
$0 Sell
4
-12
-75% -$1.04K ﹤0.01% 2133
2022
Q2
$1K Buy
16
+12
+300% +$1.13K ﹤0.01% 1672
2022
Q1
$0 Buy
+4
New +$413 ﹤0.01% 1843

Other funds holding TECH

EverSource Wealth Advisors's TECH Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Bio-Techne (TECH) stake by 32% in Q2 2026, selling an estimated $9.45K and leaving 365 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

EverSource Wealth Advisors first reported a position in TECH in Q1 2022 and has held it in 18 quarters since. The position peaked at $34.6K in Q2 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • EverSource Wealth Advisors held 365 shares of Bio-Techne worth $25.8K as of Q2 2026.
  • EverSource Wealth Advisors sold 175 Bio-Techne shares in Q2 2026, an estimated $9.45K.
  • Bio-Techne made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2249 holding.
  • EverSource Wealth Advisors first reported a position in Bio-Techne in Q1 2022 and has held it in 18 quarters since.
  • EverSource Wealth Advisors's Bio-Techne position peaked at $34.6K in Q2 2025.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.